ZNF471 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.670300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.893600E-01
Normal-vs-Stage2
6.049500E-02
Normal-vs-Stage3
3.756000E-03
Normal-vs-Stage4
6.004600E-01
Stage1-vs-Stage2
1.223940E-02
Stage1-vs-Stage3
7.337700E-02
Stage1-vs-Stage4
6.549600E-01
Stage2-vs-Stage3
3.637000E-01
Stage2-vs-Stage4
2.220600E-01
Stage3-vs-Stage4
1.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.922000E-02
Normal-vs-AfricanAmerican
7.097900E-02
Normal-vs-Asian
2.462200E-02
Caucasian-vs-AfricanAmerican
9.305000E-01
Caucasian-vs-Asian
5.780000E-01
AfricanAmerican-vs-Asian
7.265600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.063790E-01
Normal-vs-Female
4.779500E-02
Male-vs-Female
6.908000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.069800E-01
Normal-vs-Age(41-60Yrs)
3.443400E-01
Normal-vs-Age(61-80Yrs)
5.139600E-03
Normal-vs-Age(81-100Yrs)
7.723700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.978570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.260800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.862000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.007700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.384300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.622000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.701900E-02
Normal-vs-Daily Drinker
3.330000E-01
Normal-vs-Weekly Drinker
9.735800E-03
Normal-vs-Occasional Drinker
3.593900E-02
Normal-vs-Social Drinker
1.112840E-01
Non Drinker-vs-Daily Drinker
8.545800E-01
Non Drinker-vs-Weekly Drinker
9.152400E-01
Non Drinker-vs-Occasional Drinker
7.702600E-01
Non Drinker-vs-Social Drinker
2.113000E-01
Daily Drinker-vs-Weekly Drinker
9.037200E-01
Daily Drinker-vs-Occasional Drinker
9.846200E-01
Daily Drinker-vs-Social Drinker
5.939200E-01
Weekly Drinker-vs-Occasional Drinker
8.677400E-01
Weekly Drinker-vs-Social Drinker
2.916200E-01
Occasional Drinker-vs-Social Drinker
3.860200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.565400E-01
Normal-vs-Grade 2
1.406590E-01
Normal-vs-Grade 3
1.841350E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.568600E-01
Grade 1-vs-Grade 3
2.858800E-01
Grade 1-vs-Grade 4
3.565400E-01
Grade 2-vs-Grade 3
4.336000E-01
Grade 2-vs-Grade 4
1.406590E-01
Grade 3-vs-Grade 4
1.841350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.235300E-03
Normal-vs-NonDiabetic
9.224000E-02
Diabetic-vs-NonDiabetic
3.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.820600E-04
Normal-vs-NoPancreatitis
1.169790E-02
Pancreatitis-vs-NoPancreatitis
1.286440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.523600E-02
Normal-vs-N1
6.794400E-02
N0-vs-N1
9.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.239900E-03
Normal-vs-TP53-NonMutant
4.459600E-01
TP53-Mutant-vs-TP53-NonMutant
1.360010E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
